pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

7,970 catalysts · 5,347 phase readout · 2,277 8k filing · 343 pdufa · 257 earnings · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-03: 4 catalysts2026-08-04: 13 catalysts2026-08-05: 18 catalysts2026-08-06: 11 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 2 catalysts2026-08-11: 1 catalyst2026-08-12: 2 catalysts2026-08-13: 1 catalyst2026-08-14: 1 catalyst2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 1 catalyst2026-10-22: 2 catalysts2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 0 catalysts2026-10-27: 2 catalysts2026-10-28: 1 catalyst2026-10-29: 3 catalysts2026-10-30: 0 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type
  • phase readout5,347
  • 8k filing2,277
  • pdufa343
  • earnings257
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Date TBD

50
›TERMINATEDphase readoutNCT06535477: Fall Risk Assessment With an Innovative Device for Quantifying Gait and Static Balance in Geriatric Consultation

Sponsor: Gérond'if. Phase: NA. Conditions: Risk of Falling in the Elderly

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT07347457: Functional Rehabilitation Effects on Exercise-induced Hypoalgesia in Chronic Low Back Pain

Sponsor: Clinique de la Mitterie. Phase: NA. Conditions: Low Back Pain

full page →ctgov ↗
›COMPLETEDphase readoutNCT07495553: Web-Based Filial Therapy In Pediatric Cancer

Sponsor: serap güleç keskin. Phase: NA. Conditions: Pediatric Cancer, Parental Stress, Parenting Anxiety

full page →ctgov ↗
›RECRUITINGphase readoutNCT06075745: Cytomegalovirus (CMV) Vaccine in Orthotopic Liver Transplant Candidates

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID). Phase: PHASE2. Conditions: Liver Transplant

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07471672: Spot Compression Ultrasound Compared to Traditional Breast Ultrasound

Sponsor: Duke University. Phase: NA. Conditions: Breast Mass

full page →ctgov ↗
›RECRUITINGphase readoutNCT06283472: Enhancing Prospective Thinking in Early Recovery (BEAM)

Sponsor: Indiana University. Phase: NA. Conditions: Alcohol Use Disorder

full page →ctgov ↗
›TERMINATEDphase readoutNCT05899595: Effects of a Personalized Physical Training to Reduce Fatigue

Sponsor: Centre Hospitalier Universitaire de Saint Etienne. Phase: NA. Conditions: Fatigue Syndrome, Chronic

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT03513939: A Safety, Tolerability and Efficacy Study of Sernova's Cell Pouch™ for Clinical Islet Transplantation

Sponsor: Sernova Biotherapeutics Inc.. Phase: PHASE1. Conditions: Type 1 Diabetes Mellitus

full page →ctgov ↗
›COMPLETEDphase readoutNCT05289739: Exercise Training in Childhood Cancer

Sponsor: Johannes Gutenberg University Mainz. Phase: NA. Conditions: Pediatric Oncology

full page →ctgov ↗
›RECRUITINGphase readoutNCT06339177: Hemophagocytic Lymphohistiocytosis (HLH) Evaluation and Research of Clinical, ImmUnoLogic and TranscriptomE Study

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID). Phase: . Conditions: Lymphohistiocytosis, Hemophagocytic, Secondary Hemophagocytic Lymphohistiocytosis, Macrophage Activation Syndrome, Hyperinflammatory Syndromes

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07336277: Sleep Quality and the Efficacy of a Multimodal Sleep Pathway in Hospitalized Orthopedic Trauma Patients

Sponsor: Emory University. Phase: PHASE3. Conditions: Orthopedic Trauma, Sleep Quality

full page →ctgov ↗
›RECRUITINGphase readoutNCT07238075: ADCX-020 for the Treatment of Patients With Locally Advanced or Metastatic Cancers

Sponsor: Adcytherix SAS. Phase: PHASE1. Conditions: Advanced Malignancy, Advanced Solid Cancers, Metastatic Solid Tumors

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT06746675: Evaluating the Healthy Families PrEP Program for Women at Risk for HIV

Sponsor: Yale University. Phase: NA. Conditions: HIV, Pregnancy, Pre-Exposure Prophylaxis of HIV Infection

full page →ctgov ↗
›RECRUITINGphase readoutNCT06807957: Inspiratory Muscle Training in Amateur CrossFit® Athletes

Sponsor: Federal University of the Valleys of Jequitinhonha and Mucuri. Phase: NA. Conditions: Healthy

full page →ctgov ↗
›RECRUITINGphase readoutNCT06975657: Well-being Skills for Reentry

Sponsor: University of Wisconsin, Madison. Phase: NA. Conditions: Formerly Incarcerated Adults

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06050577: The Effect of Oral Semaglutide on Bone Turnover in Patients With T2D: a Randomized Placebo-controlled Clinical Trial

Sponsor: Odense University Hospital. Phase: PHASE2. Conditions: Type 2 Diabetes, Osteopenia

full page →ctgov ↗
›TERMINATEDphase readoutNCT01980277: Phase Ib/II Study of LY2780301 in Combination With Weekly PACLITAXEL in HER2-metastatic Breast Cancer

Sponsor: Institut Paoli-Calmettes. Phase: PHASE1. Conditions: Breast Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT07028372: Long Term Follow-up of Cardiac Arrest Survivors Exposed to Ultra-rapid Cooling

Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: . Conditions: Cardiac Arrest (CA), Resuscitated Sudden Cardiac Death, Post Cardiac Arrest Patient Who Was Treated by Hypothermia Protocol

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05359445: IMA401 TCER® in Recurrent and/or Refractory Solid Tumors, Alone or in Combination With a Checkpoint Inhibitor

Sponsor: Immatics Biotechnologies GmbH. Phase: PHASE1. Conditions: Refractory Cancer, Recurrent Cancer, Solid Tumor, Adult, Cancer

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07585695: Coronary Artery Disease Screening in Patients With Chronic Kidney Disease

Sponsor: University Hospital, Grenoble. Phase: . Conditions: Chronic Kidney Disease (CKD), Coronary Artery Disease (CAD)

full page →ctgov ↗
›RECRUITINGphase readoutNCT05408845: Testing the Use of Ado-Trastuzumab Emtansine Compared to the Usual Treatment (Chemotherapy With Docetaxel Plus Trastuzumab) or Trastuzumab Deruxtecan for Recurrent, Metastatic, or Unresectable HER2-Expressing Salivary Gland Cancers

Sponsor: NRG Oncology. Phase: PHASE2. Conditions: Metastatic Salivary Gland Carcinoma, Recurrent Salivary Gland Carcinoma, Stage III Major Salivary Gland Cancer AJCC v8, Stage IV Major Salivary Gland Cancer AJCC v8, Unresectable Salivary Gland Carcinoma

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT00515372: Depression Treatment and Screening in Ovarian Cancer Patients

Sponsor: M.D. Anderson Cancer Center. Phase: PHASE1. Conditions: Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT06814795: Medically Tailored Meals for Kids

Sponsor: UNC Lineberger Comprehensive Cancer Center. Phase: NA. Conditions: Pediatric Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT07542431: Impact of Dog Adoption and Training in Veterans With Post-traumatic Stress Symptoms and/or Other Mental Health Conditions

Sponsor: Florida Atlantic University. Phase: NA. Conditions: Posttraumatic Stress Symptoms, Mental Health Conditions

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05763602: PVI to Prevent S. Aureus SSI After Fixation of HELEF (POTENT Study)

Sponsor: Loreen Herwaldt. Phase: PHASE4. Conditions: Surgical Site Infection

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07550439: Effect of World Health Organization Labour Care Guide On Reducing Cesarean Section Rates

Sponsor: Pak Emirates Military Hospital. Phase: NA. Conditions: Labour

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07602465: The Impact of Blood Pressure Variability During the Induction and Surgical Periods on Postoperative Acute Kidney Injury

Sponsor: Zhongda Hospital. Phase: . Conditions: Acute Kidney Injury (AKI)

full page →ctgov ↗
›RECRUITINGphase readoutNCT03773965: A Study of Baricitinib in Participants From 1 Year to Less Than 18 Years Old With Juvenile Idiopathic Arthritis

Sponsor: Eli Lilly and Company. Phase: PHASE3. Conditions: Juvenile Idiopathic Arthritis

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07413965: TAVR vs SAVR in Severe Bicuspid Aortic Stenosis

Sponsor: Cedars-Sinai Medical Center. Phase: NA. Conditions: Bicuspid Aortic Valve Disease

full page →ctgov ↗
›RECRUITINGphase readoutNCT06923267: Ultrasound Evaluation of Cardiac Function During Spontaneous Breathing Trials

Sponsor: Centre Hospitalier Régional d'Orléans. Phase: NA. Conditions: Weaning Invasive Mechanical Ventilation, Weaning-induced Pulmonary Edema, Weaning Failure of Mechanical Ventilation, Spontaneous Breathing Test, Intensive Care Units (ICUs)

full page →ctgov ↗
›RECRUITINGphase readoutNCT07545967: Re-radiotherapy Combined With Chidamide for the Treatment of Recurrent Head and Neck Squamous Cell Carcinoma After Radiotherapy

Sponsor: West China Hospital. Phase: PHASE1. Conditions: Head and Neck Squamous Cell Carcinoma HNSCC

full page →ctgov ↗
›RECRUITINGphase readoutNCT07196007: Leveraging Community-clinical Linkages to Address Unmet Social Needs for People With Diabetes

Sponsor: Mary Lacy. Phase: NA. Conditions: Diabetes, Diabetes Mellitus

full page →ctgov ↗
›COMPLETEDphase readoutNCT00862992: Safety, Pharmacokinetics and Efficacy Study of MP-214 in Patients With Schizophrenia

Sponsor: Tanabe Pharma Corporation. Phase: PHASE2. Conditions: Schizophrenia

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07612592: The Clinical Application Study of Obinutuzumab in Pediatric Refractory Nephrotic Syndrome

Sponsor: Children's Hospital of Chongqing Medical University. Phase: . Conditions: Primary Nephrotic Syndrome

full page →ctgov ↗
›RECRUITINGphase readoutNCT04972136: rTMS for Depression in Young Adults With Autism

Sponsor: Centre for Addiction and Mental Health. Phase: NA. Conditions: Autism Spectrum Disorder, Major Depressive Disorder

full page →ctgov ↗
›COMPLETEDphase readoutNCT01805336: Assessment of Attentional and Executive Disorders in Multiple Sclerosis Using Techniques of Virtual Reality

Sponsor: University Hospital, Caen. Phase: NA. Conditions: Relapsing-Remitting Multiple Sclerosis

full page →ctgov ↗
›RECRUITINGphase readoutNCT07097311: Study to Evaluate the Use of Triheptanoin in Patients With Medium Chain Acyl-CoA Dehydrogenase Deficiency (MCADD)

Sponsor: Jerry Vockley, MD, PhD. Phase: PHASE2. Conditions: Medium-chain Acyl-CoA Dehydrogenase Deficiency

full page →ctgov ↗
›TERMINATEDphase readoutNCT04519671: Mesenchymal Stem Cells for the Treatment of Perianal Fistulizing Crohn's Disease

Sponsor: Anthony Lembo. Phase: PHASE1. Conditions: Perianal Crohn Disease, Perianal Fistula, Crohn Disease

full page →ctgov ↗
›RECRUITINGphase readoutNCT07436364: Application of Contrast-enhanced Ultrasound in Monitoring Soft Tissue Sarcoma Response to Neoadjuvant Radiotherapy

Sponsor: Thomas Jefferson University. Phase: EARLY_PHASE1. Conditions: Soft Tissue Sarcoma

full page →ctgov ↗
›TERMINATEDphase readoutNCT04548609: Transcranial Direct Current Stimulation (tDCS) in Pediatric Obsessive Compulsive Disorder (OCD)

Sponsor: Massachusetts General Hospital. Phase: NA. Conditions: Obsessive-Compulsive Disorder, Pediatric Psychiatric Disorder

full page →ctgov ↗
›RECRUITINGphase readoutNCT04328298: French Register Of Patients With Hemopathy Eligible For CAR-T Cell Treatment (DESCAR-T)

Sponsor: The Lymphoma Academic Research Organisation. Phase: . Conditions: Hematopathology Eligible or CAR-t Cell Treatment

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05565599: An Early Feasibility Study Evaluating the Safety and Efficacy of the Laminar Left Atrial Appendage Closure System in Subjects With Non-Valvular Atrial Fibrillation

Sponsor: Biosense Webster, Inc.. Phase: NA. Conditions: Non-valvular Atrial Fibrillation

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07404098: Efficacy Of Eggshell-Derived Nanohydroxyapatite Based Mineralized Plasmatic Matrix Versus Xenogeneic Based Mineralized Plasmatic Matrix in Posterior Mandibular Socket Preservation

Sponsor: Cairo University. Phase: NA. Conditions: Alveolar Bone Resorption, Socket Preservation, Wound Healing, Nano-hydroxyapatite

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07216963: The Community Paramedic Response and Overdose Outreach With Supportive Medical-Legal Services Study

Sponsor: Duke University. Phase: NA. Conditions: Opioid Use Disorder, Overdose, Drug, Overdose, Substance Use (Drugs, Alcohol)

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07288463: Hearing Loss and Brain Health Study

Sponsor: University of Southern California. Phase: NA. Conditions: Hearing Loss, Adult-Onset, Dementia

full page →ctgov ↗
›RECRUITINGphase readoutNCT07139314: Timing of Anticoagulation After Emergency Endovascular Therapy for Acute Ischemic Stroke With Atrial Fibrillation 2

Sponsor: Capital Medical University. Phase: NA. Conditions: Ischemic Stroke, Atrial Fibrillation

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06993116: A Phase I Study of SHR-4712 in Patients With Advanced Solid Tumors

Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd. Phase: PHASE1. Conditions: Advanced Solid Tumor

full page →ctgov ↗
›RECRUITINGphase readoutNCT03126916: Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)

Sponsor: Children's Oncology Group. Phase: PHASE3. Conditions: Ganglioneuroblastoma, Ganglioneuroblastoma, Nodular, Neuroblastoma

full page →ctgov ↗
›RECRUITINGphase readoutNCT04744116: Addition of Cord Blood Tissue-Derived Mesenchymal Stromal Cells to Ruxolitinib for the Treatment of Steroid-Refractory Acute Graft Versus Host Disease

Sponsor: M.D. Anderson Cancer Center. Phase: EARLY_PHASE1. Conditions: Hematopoietic and Lymphoid Cell Neoplasm, Steroid Refractory Graft Versus Host Disease

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07410052: Microbiome-Targeted Enhancement of Neurocognition With Probiotics-Riboflavin Combination

Sponsor: Center for Health Sciences, Serbia. Phase: NA. Conditions: Cognitive Deficits, Mild

full page →ctgov ↗
← prev
page 92 of 160
next →